Page last updated: 2024-10-30

lansoprazole and Argentaffinoma

lansoprazole has been researched along with Argentaffinoma in 3 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Attila, T1
Santharam, R1
Blom, D1
Komorowski, R1
Koch, TR1
Arnold, R1
Haga, Y1
Nakatsura, T1
Shibata, Y1
Sameshima, H1
Nakamura, Y1
Tanimura, M1
Ogawa, M1

Other Studies

3 other studies available for lansoprazole and Argentaffinoma

ArticleYear
Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole.
    Digestive diseases and sciences, 2005, Volume: 50, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anemia, Pernicious; Biopsy, Needle; Carcinoid Tumor; Female

2005
[What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Fortschritte der Medizin, 1994, Jan-20, Volume: 112, Issue:1-2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Carcinogenicity Tests; Carcinoi

1994
Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Carcinoid Tumor; Famotidine; Hist

1998